Enhanced Product Catalog API - The new API release introduces bundling and pricing capabilities to better define and automate NaaS service offerings. By providing a machine-readable product schema, ...

Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced its abstract has been accepted ...

(Nasdaq: AGEN), a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research (AACR) IO Annual Meeting that ...

INOVIO (NASDAQ: INO) has announced that new research on its investigational immunotherapy, INO-3107, will be presented at the ...

Flatiron Health today announced its planned presence at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), including three accepted abstracts for poster presentation.

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

Pro-Palestinian activists have seemingly put up anti-Israeli posters on the London Underground, accusing Britain of spying on behalf of Israel. An image of the advert, on the Jubilee Line at London ...

A phase 1/2 study to evaluate CHM-2101, an autologous cadherin 17 (CDH17) chimeric antigen receptor (CAR) T cell therapy for the treatment of relapsed or refractory gastrointestinal cancers. Phase 1/2 ...

Captain America: Brave New World is nearly here and Marvel Thailand has just dropped a couple of unique posters to hype up the movie's release. While we obviously won't see these costumes in The ...

Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...

The FDA-AACR workshop came about at the urging of Karen Merritt, who began advocating for pretreatment DPYD testing after her mother died after her first 5-FU infusion due to an unknown deficiency of ...